ABERNETHY MATT (Chief Financial Officer) exercised options at NEUROCRINE BIOSCIENCES INC
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/3/2026ACC: 0001724097-26-000003
Officer· Chief Financial Officer
Since Mar 2026
-1.37K
Net shares
Net seller
$186.1K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
2.44K acquired · 3.81K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.44K
Price / share
—
Trade value
—
% of position
6.8%
1/31/2026
36.03K→38.47K
Common Stock
Direct
Shares
−1.37K
Price / share
$136.06
Trade value
$186.13K
% of position
3.6%
1/31/2026
38.47K→37.10K
Total
Net shares
+1.07K
Net value
-$186.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2026 | M · Option Exercise | +2.44K | — | — | 6.8% | 36.03K | 38.47K |
| Common Stock Direct | 1/31/2026 | F · Tax Withholding | −1.37K | $136.06 | $186.13K | 3.6% | 38.47K | 37.10K |
| Total | +1.07K | -$186.13K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
2.44K shares
Shares
−2.44K
Strike price
Held after
0.00
Exercisable
—
1/31/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock2.44K shares | 1/31/2026 | M · Option Exercise | −2.44K | — | 0.00 |